# 117-hr-8877: Biologics Competition Act of 2022

117-hr-8877, Biologics Competition Act of 2022, is a 117th Congress bill sponsored by Rep. Miller-Meeks, Mariannette [R-IA-1] (R-IA); status Referred to the Subcommittee on Health. (as of 2025-11-18).

- Canonical: https://policyrisk.com/legislation/117-hr-8877
- As of: 2025-11-18
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 117-hr-8877
- Congress: 117
- Title: Biologics Competition Act of 2022
- Status: Referred to the Subcommittee on Health.
- Introduced: 2022-09-19
- Sponsor: Rep. Miller-Meeks, Mariannette [R-IA-1] (R-IA)
- Cosponsors: 4
- Policy area: Health
- Touches household money: no
- Last recorded action: 2025-11-18

## Summary

Biologics Competition Act of 2022 This bill requires the Food and Drug Administration (FDA) to evaluate (1) the differences between the requirements that apply to interchangeable biologics and the requirements that apply to therapeutically equivalent ratings for generic drugs, and (2) the effects of these differences on the approval of interchangeable biologics. The FDA must update the Purple Book with changes that better align the ways these requirements are communicated while still maintaining each distinct approval pathway. The Purple Book is an FDA publication that lists approved biological products, including biosimilars and interchangeable biologics. Interchangeable biologics are biologics that may be substituted for the original product without consulting the prescriber, similar to how generic drugs may be substituted for brand-name drugs based on therapeutic equivalence.

## Cosponsors (4)

- Rep. Murphy, Gregory F. [R-NC-3] (R-NC), 2022-09-19T00:00:00.000Z
- Rep. Barragán, Nanette Diaz [D-CA-44] (D-CA), 2022-09-19T00:00:00.000Z
- Rep. Kuster, Ann M. [D-NH-2] (D-NH), 2022-09-19T00:00:00.000Z
- Rep. Bice, Stephanie I. [R-OK-5] (R-OK), 2022-09-29T00:00:00.000Z

## Related bills

- 117-hr-1448: PAWS for Veterans Therapy Act
- 117-hr-3537: Accelerating Access to Critical Therapies for ALS Act
- 117-hr-1193: Cardiovascular Advances in Research and Opportunities Legacy Act
- 117-hr-5142: To award posthumously a Congressional Gold Medal, in commemoration to the servicemembers who perished in Afghanistan on August 26, 2021, during the evacuation…
- 117-hres-881: Condemning the heinous terrorist attack on Congregation Beth Israel in Colleyville, Texas, on January 15, 2022.
- 117-hr-3630: Lymphedema Treatment Act

## Sources
- [117-hr-8877 on Congress.gov](https://www.congress.gov/bill/117th-congress/house-bill/8877)

## Related
- [117-hr-1448: PAWS for Veterans Therapy Act](https://policyrisk.com/legislation/117-hr-1448)
- [117-hr-3537: Accelerating Access to Critical Therapies for ALS Act](https://policyrisk.com/legislation/117-hr-3537)
- [117-hr-1193: Cardiovascular Advances in Research and Opportunities Legacy Act](https://policyrisk.com/legislation/117-hr-1193)
- [117-hr-5142: To award posthumously a Congressional Gold Medal, in commemoration to the servi…](https://policyrisk.com/legislation/117-hr-5142)
- [117-hres-881: Condemning the heinous terrorist attack on Congregation Beth Israel in Colleyvi…](https://policyrisk.com/legislation/117-hres-881)
- [117-hr-3630: Lymphedema Treatment Act](https://policyrisk.com/legislation/117-hr-3630)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/117-hr-8877 (as of 2025-11-18).